Initiation, adherence to AIs low for older women with DCIS

(HealthDay)—For older women with estrogen receptor (ER)-positive ductal carcinoma in situ (DCIS), initiation of aromatase inhibitors (AIs) and adherence to treatment are low, according to a study published online Oct. 25 in Cancer.

Half of DCIS-treated women don't get ongoing imaging surveillance

PDF) Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: A systematic review

Accuracy of breast MRI in patients receiving neoadjuvant endocrine therapy: comprehensive imaging analysis and correlation with clinical and pathological assessments

Current Oncology, Free Full-Text

PDF) Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II - ScienceDirect

Full article: Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study

Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ - Zhao - 2017 - Cancer - Wiley Online Library

Full article: Good adherence to adjuvant endocrine therapy in early breast cancer – a population-based study based on the Swedish Prescribed Drug Register

Early participant-reported symptoms as predictors of adherence to anastrozole in the International Breast Cancer Intervention Studies II - Annals of Oncology

Adjuvant Hormonal Therapy Adherence in Breast Cancer - BCTT

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer Attending the Tikur Anbessa Specialized Hospital, Addis Ababa Ethiopia, 2019: A Cross-sectional Study. - Abstract - Europe PMC